risedronic acid has been researched along with Angiogenesis, Pathologic in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stresing, V | 1 |
| Fournier, PG | 1 |
| Bellahcène, A | 1 |
| Benzaïd, I | 1 |
| Mönkkönen, H | 1 |
| Colombel, M | 1 |
| Ebetino, FH | 1 |
| Castronovo, V | 1 |
| Clézardin, P | 1 |
1 other study available for risedronic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; | 2011 |